NWXUX | PUVCX | NWXUX / PUVCX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 8 years | 25 years | - |
Gain YTD | 2.943 | 3.147 | 94% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000000 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 285M | 303M | 94% |
Annual Yield % from dividends | 2.37 | 0.00 | - |
Returns for 1 year | 6.39 | 5.61 | 114% |
Returns for 3 years | -16.75 | -12.04 | 139% |
Returns for 5 years | 7.75 | 0.74 | 1,051% |
Returns for 10 years | N/A | 20.13 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
JNGLX | 69.96 | 0.07 | +0.10% |
Janus Henderson Global Life Sciences D | |||
RGRLX | 11.09 | N/A | N/A |
RBC Global Equity Leaders R6 | |||
PXGOX | 17.22 | -0.03 | -0.17% |
Impax Global Opportunities Institutional | |||
FEVCX | 19.79 | -0.13 | -0.65% |
First Eagle US Value C | |||
VBCVX | 15.41 | -0.12 | -0.77% |
VALIC Company I Systematic Value |